Related references
Note: Only part of the references are listed.Randomized controlled trial of atorvastatin in clinically isolated syndrome The STAyCIS study
E. Waubant et al.
NEUROLOGY (2012)
Interferon regulatory factor 8 integrates T-cell receptor and cytokine- signaling pathways and drives effector differentiation of CD8 T cells
Fumi Miyagawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis
Jennifer M. Kress-Bennett et al.
BMC NEUROLOGY (2011)
The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation
David M. Kofler et al.
JOURNAL OF IMMUNOLOGY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Multiple sclerosis susceptibility alleles in African Americans
B. A. Johnson et al.
GENES AND IMMUNITY (2010)
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
F. Esposito et al.
GENES AND IMMUNITY (2010)
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci
Jacob L. McCauley et al.
HUMAN MOLECULAR GENETICS (2010)
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
Maria Ban et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
The expanding genetic overlap between multiple sclerosis and type I diabetes
David R. Booth et al.
GENES AND IMMUNITY (2009)
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Sergio E. Baranzini et al.
HUMAN MOLECULAR GENETICS (2009)
Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis
Ilse A. Hoppenbrouwers et al.
JOURNAL OF HUMAN GENETICS (2009)
The onset location of multiple sclerosis predicts the location of subsequent relapses
E. M. Mowry et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Melanie Bahlo et al.
NATURE GENETICS (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
The role of the CD58 locus in multiple sclerosis
Philip L. De Jager et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Predictors of the location of multiple sclerosis relapse
S. Deen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis
J. Toledo et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis
Simon G. Gregory et al.
NATURE GENETICS (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Interferon β-1a for early multiple sclerosis:: CHAMPS trial subgroup analyses
RW Beck et al.
ANNALS OF NEUROLOGY (2002)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)